Genenta Science S.p.A GNTA
NASDAQ GNTA
$1.26 +0.07 (+5.88%)
At close: Aug 21, 2026 · 4:00 PM EDT

Genenta Science S.p.A (GNTA) Other Accumulated Expenses (2020 - 2025)

Genenta Science S.p.A (GNTA) posted Other Accumulated Expenses of $138521.2 for Q4 2025, down 50.07% sequentially from $277450.1 in Q2 2025, and down 61.62% YoY from $360933.1 in Q4 2024.

Genenta Science S.p.A (GNTA) Other Accumulated Expenses (2020 - 2025) Analysis & Trends

Genenta Science S.p.A has reported Other Accumulated Expenses for 6 years, with the latest figure at $138521.2 in Q4 2025.

  • Quarterly Other Accumulated Expenses fell 61.62% year-over-year to $138521.2 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $138521.2 (down 61.62% YoY) and the FY2025 annual result came in at $138521.2, down 61.62% from the prior year.
  • Other Accumulated Expenses declined to $138521.2 in Q4 2025 per GNTA's latest filing, from $277450.1 in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $475226.2 in Q2 2024 and troughed at $115219.6 in Q4 2021.
  • A 5-year average of $256007.0 and a median of $274431.4 in 2023 frame the typical range for Other Accumulated Expenses.
  • The sharpest annual moves came in 2022 and 2025: Other Accumulated Expenses jumped 163.76% in 2022, then sank 61.62% in 2025.
  • Over 5 years, Other Accumulated Expenses stood at $115219.6 in 2021, then surged by 163.76% to $303906.2 in 2022, then decreased by 9.7% to $274431.4 in 2023, then jumped by 31.52% to $360933.1 in 2024, then tumbled by 61.62% to $138521.2 in 2025.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods registered $138521.2, $277450.1, and $360933.1 for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Genenta Science S.p.A 25.03 Mn -34.07 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 138,521.18
Jun 30, 2025 277,450.11
Dec 31, 2024 360,933.06
Jun 30, 2024 475,226.18
Dec 31, 2023 274,431.39
Jun 30, 2023 230,059.23
Dec 31, 2022 303,906.18
Jun 30, 2022 128,315.70
Dec 31, 2021 115,219.61
Dec 31, 2020 63,481.09